Financial insights of MMED

MyFinsight

For the quarter ending 2026-01-23, MMED made $790M in revenue. -$119M in net income. Net profit margin of -15.06%.

Income Statement	2026-01-23
Net sales	790
Cost of products sold	428
Gross profit	362
Research and development expense	114
Selling, general, and administrative expense	309
Certain litigation charges, net	6
Other operating expense (income), net	-45
Operating (loss) profit	-100
Other non-operating (income) expense, net	0
(loss) profit before income taxes	-99
Income tax provision	12
Net loss	-111
Net income attributable to noncontrolling interests	8
Net loss attributable to the company	-119

Basic EPS	-0.47
Diluted EPS	-0.47
Basic Average Shares	252,813,348
Diluted Average Shares	252,813,348

Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.